Td. Reil et al., Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation, J SURG RES, 92(1), 2000, pp. 108-113
We have previously demonstrated that dexamethasone (DEX) suppresses neointi
mal hyperplasia and proliferation of rat aortic smooth muscle cells (SMC) b
y inducing a late G1 phase cell cycle arrest. Phosphorylation of retinoblas
toma protein (Rb) regulates cell proliferation by controlling progression f
rom G1 to S phase of the cell cycle. We hypothesized that DEX inhibits huma
n vascular SMC proliferation and causes cell cycle arrest through inhibitio
n of Rb phosphorylation. Human aortic SMC were cultured and treated with in
cremental doses of DEX. Cell counts and [H-3]thymidine uptake were determin
ed after 72 h. To examine the effects of DEX on the cell cycle, cells were
synchronized by serum deprivation, restimulated to enter G1 phase, and trea
ted with 10(-5) M DEX, and protein was extracted at sequential time points.
Flow cytometry was performed to track cell cycle progression. Western blot
s were performed to examine Rb phosphorylation. DEX inhibited smooth muscle
cell proliferation and DNA synthesis in a concentration-dependent fashion.
Flow cytometry indicated that DEX induces a G1 phase cell cycle arrest, DE
X inhibited the phosphorylation of Rb protein compared to control. DEX inhi
bits the proliferation of human vascular SMC by inducing G1 phase cell cycl
e arrest, DEX inhibited the phosphorylation of Rb, a key step in the progre
ssion of the cell from G1 to S phase, Elucidation of the mechanism of DEX m
ay be helpful in treatment strategies for preventing neointimal hyperplasia
as well as other disorders of cell proliferation. (C) 2000 Academic Press.